Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-26 @ 3:18 AM
NCT ID:
NCT04185220
Group ID:
EG000
Title:
Dose Level 1 (Interleukin-15 2mcg/kg/Day)
Description:
Interleukin-15 (IL-15) by continuous intravenous (CIV) infusion at 2 mcg/kg/day on days 1-5 of each 28-day cycle (max 6 cycles) with mogamulizumab by intravenous (IV) infusion at a dose of 1 mg/kg days 1, 8, 15 and 22 of cycle 1 and days 1 and 15 of each subsequent cycle to determine MTD.
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
3
Serious Number At Risk:
3
Other Number Affected:
3
Other Number At Risk:
3
Study:
NCT04185220
Results Section:
NCT04185220
Adverse Events Module:
NCT04185220